Neurometrix Stock Short Ratio
| NURO Stock | USD 4.25 0.10 2.41% |
NeuroMetrix fundamentals help investors to digest information that contributes to NeuroMetrix's financial success or failures. It also enables traders to predict the movement of NeuroMetrix Stock. The fundamental analysis module provides a way to measure NeuroMetrix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NeuroMetrix stock.
NeuroMetrix | Short Ratio |
NeuroMetrix Company Short Ratio Analysis
NeuroMetrix's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current NeuroMetrix Short Ratio | 1.12 X |
Most of NeuroMetrix's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NeuroMetrix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
NeuroMetrix Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for NeuroMetrix is extremely important. It helps to project a fair market value of NeuroMetrix Stock properly, considering its historical fundamentals such as Short Ratio. Since NeuroMetrix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of NeuroMetrix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of NeuroMetrix's interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
NeuroMetrix Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, NeuroMetrix has a Short Ratio of 1.12 times. This is 71.28% lower than that of the Health Care Equipment & Supplies sector and 70.29% lower than that of the Health Care industry. The short ratio for all United States stocks is 72.0% higher than that of the company.
NeuroMetrix Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NeuroMetrix's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NeuroMetrix could also be used in its relative valuation, which is a method of valuing NeuroMetrix by comparing valuation metrics of similar companies.NeuroMetrix is currently under evaluation in short ratio category among its peers.
NeuroMetrix ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, NeuroMetrix's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to NeuroMetrix's managers, analysts, and investors.Environmental | Governance | Social |
NeuroMetrix Institutional Holders
Institutional Holdings refers to the ownership stake in NeuroMetrix that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of NeuroMetrix's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing NeuroMetrix's value.| Shares | Harbour Investments, Inc. | 2024-06-30 | 11.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Ubs Group Ag | 2024-06-30 | 0.0 | Corecap Advisors, Llc | 2024-06-30 | 0.0 | Vanguard Group Inc | 2024-09-30 | 15.1 K | Geode Capital Management, Llc | 2024-06-30 | 13.7 K | Citadel Advisors Llc | 2024-06-30 | 12.2 K | Advisor Group Holdings, Inc. | 2024-06-30 | 6.7 K | Blackrock Inc | 2024-06-30 | 5 K | Tower Research Capital Llc | 2024-06-30 | 1.7 K | Accent Capital Management Llc | 2024-06-30 | 625 |
NeuroMetrix Fundamentals
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.28 | ||||
| Profit Margin | (2.04) % | ||||
| Operating Margin | (2.97) % | ||||
| Current Valuation | (6.21 M) | ||||
| Shares Outstanding | 2.04 M | ||||
| Shares Owned By Insiders | 25.45 % | ||||
| Shares Owned By Institutions | 3.01 % | ||||
| Number Of Shares Shorted | 15.78 K | ||||
| Price To Earning | 6.51 X | ||||
| Price To Book | 0.53 X | ||||
| Price To Sales | 2.30 X | ||||
| Revenue | 5.9 M | ||||
| Gross Profit | 5.75 M | ||||
| EBITDA | (7.1 M) | ||||
| Net Income | (6.53 M) | ||||
| Cash And Equivalents | 20.83 M | ||||
| Cash Per Share | 2.68 X | ||||
| Total Debt | 240.88 K | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 12.79 X | ||||
| Book Value Per Share | 7.99 X | ||||
| Cash Flow From Operations | (6.08 M) | ||||
| Short Ratio | 1.12 X | ||||
| Earnings Per Share | (4.62) X | ||||
| Price To Earnings To Growth | (0.01) X | ||||
| Target Price | 50.0 | ||||
| Number Of Employees | 26 | ||||
| Beta | 2.3 | ||||
| Market Capitalization | 8.68 M | ||||
| Total Asset | 21.42 M | ||||
| Retained Earnings | (210.11 M) | ||||
| Working Capital | 19.61 M | ||||
| Current Asset | 10.59 M | ||||
| Current Liabilities | 3.59 M | ||||
| Net Asset | 21.42 M |
About NeuroMetrix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NeuroMetrix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeuroMetrix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeuroMetrix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with NeuroMetrix
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeuroMetrix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroMetrix will appreciate offsetting losses from the drop in the long position's value.Moving against NeuroMetrix Stock
The ability to find closely correlated positions to NeuroMetrix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeuroMetrix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeuroMetrix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeuroMetrix to buy it.
The correlation of NeuroMetrix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeuroMetrix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeuroMetrix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeuroMetrix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out NeuroMetrix Piotroski F Score and NeuroMetrix Altman Z Score analysis. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.62) | Revenue Per Share 2.157 | Quarterly Revenue Growth (0.51) | Return On Assets (0.28) | Return On Equity (0.43) |
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.